Physico-chemical aspects of lactose for inhalation
- PMID: 22123598
- DOI: 10.1016/j.addr.2011.11.004
Physico-chemical aspects of lactose for inhalation
Abstract
A dry powder inhaler (DPI) is a dosage form that consists of a powder formulation in a device which is designed to deliver an active ingredient to the respiratory tract. It has been extensively investigated over the past years and several aspects relating to device and particulate delivery mechanisms have been the focal points for debate. DPI formulations may or may not contain carrier particles but whenever a carrier is included in a commercial formulation, it is almost invariably lactose monohydrate. Many physicochemical properties of the lactose carrier particles have been reported to affect the efficiency of a DPI. A number of preparation methods have been developed which have been claimed to produce lactose carriers with characteristics which lead to improved deposition. Alongside these developments, a number of characterization methods have been developed which have been reported to be useful in the measurement of key properties of the particulate ingredients. This review describes the various physicochemical characteristics of lactose, methods of manufacturing lactose particulates and their characterization.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Lactose characteristics and the generation of the aerosol.Adv Drug Deliv Rev. 2012 Mar 15;64(3):233-56. doi: 10.1016/j.addr.2011.05.003. Epub 2011 May 13. Adv Drug Deliv Rev. 2012. PMID: 21616107 Review.
-
Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.Adv Drug Deliv Rev. 2012 Mar 15;64(3):275-84. doi: 10.1016/j.addr.2011.07.002. Epub 2011 Jul 18. Adv Drug Deliv Rev. 2012. PMID: 21782866 Review.
-
Dry powders for oral inhalation free of lactose carrier particles.Adv Drug Deliv Rev. 2014 Aug;75:32-52. doi: 10.1016/j.addr.2014.04.005. Epub 2014 Apr 13. Adv Drug Deliv Rev. 2014. PMID: 24735676 Review.
-
Effect of carrier particle shape on dry powder inhaler performance.Int J Pharm. 2011 Dec 12;421(1):12-23. doi: 10.1016/j.ijpharm.2011.09.010. Epub 2011 Sep 17. Int J Pharm. 2011. PMID: 21945739
-
A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?Adv Drug Deliv Rev. 2012 Mar 15;64(3):257-74. doi: 10.1016/j.addr.2011.04.004. Epub 2011 Apr 23. Adv Drug Deliv Rev. 2012. PMID: 21565232 Review.
Cited by
-
Influence of physical properties of carrier on the performance of dry powder inhalers.Acta Pharm Sin B. 2016 Jul;6(4):308-18. doi: 10.1016/j.apsb.2016.03.011. Epub 2016 May 4. Acta Pharm Sin B. 2016. PMID: 27471671 Free PMC article. Review.
-
Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.Int J Pharm. 2019 Sep 10;568:118504. doi: 10.1016/j.ijpharm.2019.118504. Epub 2019 Jul 9. Int J Pharm. 2019. PMID: 31299339 Free PMC article.
-
Effect of Lactose Pseudopolymorphic Transition on the Aerosolization Performance of Drug/Carrier Mixtures.Pharmaceutics. 2019 Nov 4;11(11):576. doi: 10.3390/pharmaceutics11110576. Pharmaceutics. 2019. PMID: 31689975 Free PMC article.
-
Advanced Manufacturing Methods for High-Dose Inhalable Powders.Pharmaceutics. 2025 Mar 12;17(3):359. doi: 10.3390/pharmaceutics17030359. Pharmaceutics. 2025. PMID: 40143023 Free PMC article. Review.
-
Preparation of slab-shaped lactose carrier particles for dry powder inhalers by air jet milling.Asian J Pharm Sci. 2017 Jan;12(1):59-65. doi: 10.1016/j.ajps.2016.09.002. Epub 2016 Sep 21. Asian J Pharm Sci. 2017. PMID: 32104314 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous